Rockwell Medical Announces Product Purchase Agreement with Leading Provider of Home and Acute Care Dialysis Page 1

Rockwell Medical, Inc. (the “Company”) (Nasdaq: RMTI), a healthcare company that develops, manufactures, markets and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced a product purchase agreement with the leading home and acute care dialysis provider in the United States (the “Customer”). Under the terms of the agreement, Rockwell Medical will supply Customer with the Company’s RenalPure liquid acid and SteriLyte liquid bicarbonate, both packaged in the Company’s four-per-case packaging for larger dialysis settings or two-per-case packaging for smaller acute care and home care settings.

“This customer has a leading patient-centric care model that addresses the increasing demand for technological advancements in the dialysis industry,” said Tim Chole, Chief Commercial Officer at Rockwell Medical. “The underserved home hemodialysis segment presents an exciting evolution, offering patients an alternative to traveling, in many cases several hours, multiple times per week to receive their life-sustaining hemodialysis treatments. We are pleased to be this customer’s preferred supplier, domestically and internationally, for liquid acid and liquid bicarbonate hemodialysis concentrate products. Additionally, we are proud to support this customer’s vision to transform the dialysis experience for patients and make dialysis available anytime, anywhere.”